CancerCare: Metastatic Pheochromocytoma and Paraganglioma
Not Funded
About
CancerCare: Metastatic Pheochromocytoma and Paraganglioma program offers significant financial support and access to essential cancer drugs like Temodar, Cyclophosphamide, Temozolomide, Lutathera, Demser, and IGIV. The CancerCare program, specifically designed for patients with metastatic pheochromocytoma and paraganglioma, provides up to $15,000 in grants to cover co-payments and coinsurance, assisting with treatment-related expenses. The program ensures patients with federal health insurance can maintain their treatment plans effectively.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
Enrollment Form
Benefits
•$15000 annual maximum benefit
Program Requirements
•Valid only for residents in the US and Puerto Rico
•Enrollment Required: Yes
•Coverage Required: No
•Needs Based: Yes
•Activation Required: No
Program Details
•Please note the following:
•1. CancerCare covers any cancer drugs that are covered by the patient’s primary insurance and that are included in the NCCN guidelines for that cancer diagnosis
•2. Patients with private insurance must apply to manufacturer programs first before they apply to CancerCare
•Patients can enroll online but should first call 18008134673 to speak with a CancerCare social worker for a brief interview (MonThurs 10am6pm ET, and Fri 10am5pm ET)
•If eligible, patients will be mailed/emailed an individualized barcoded application and income documentation will be requested
•Patients must then submit their completed application forms and requested documentation by uploading the information to their patient portal, or via fax or email to the correct CancerCare fax number or email address listed on the application
•Acceptable income documentation includes the first 2 pages of signed income tax return, copy of most recent pay stub, unemployment check, or SSI, SSD, or public assistance benefit notification. Applicants without any source of income may provide a letter of support from friend or family member
•Grants are renewable; CancerCare will reach out to patients 60 days before the end of their term (enrollment is 12 months rolling – not based on calendar year)
•Program has funding to cover copayment and coinsurance for chemotherapy or targeted treatment medications only; any charges for scans, radiation or symptom management medicines are not covered
•Program can also assist with treatmentrelated expenses such as transportation, home care, and childcare costs; See the following link: https://www.cancercare.org/financial
•Initial grant amount is $10,000; maximum grant amount is $15,000
•Diagnosis Codes: ICD10: C74.10, C74.11, C74.12, D44.7 w/metastatic disease
Enrollment Forms
Enrollment Form